117 related articles for article (PubMed ID: 18600185)
1. Utility of serum antimüllerian hormone/Müllerian-inhibiting substance for predicting ovarian reserve in older women.
Berin I; Teixeira J
Menopause; 2008; 15(5):824-6. PubMed ID: 18600185
[No Abstract] [Full Text] [Related]
2. Body size affects measures of ovarian reserve in late reproductive age women.
Su HI; Sammel MD; Freeman EW; Lin H; DeBlasis T; Gracia CR
Menopause; 2008; 15(5):857-61. PubMed ID: 18427357
[TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
4. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions].
Yu M; Deng CY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
De Pergola G; Maldera S; Tartagni M; Pannacciulli N; Loverro G; Giorgino R
Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
[TBL] [Abstract][Full Text] [Related]
6. Ovarian reserve screening in infertility: practical applications and theoretical directions for research.
Sills ES; Alper MM; Walsh AP
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):30-6. PubMed ID: 19487066
[TBL] [Abstract][Full Text] [Related]
7. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
8. [Oocyte quality and ovarian reserve].
Hazout A
J Gynecol Obstet Biol Reprod (Paris); 2006 Sep; 35(5 Pt 2):2S35-2S36. PubMed ID: 17057620
[TBL] [Abstract][Full Text] [Related]
9. Antimüllerian hormone serum levels: a putative marker for ovarian aging.
de Vet A; Laven JS; de Jong FH; Themmen AP; Fauser BC
Fertil Steril; 2002 Feb; 77(2):357-62. PubMed ID: 11821097
[TBL] [Abstract][Full Text] [Related]
10. Data-driven assessment of the human ovarian reserve.
Kelsey TW; Anderson RA; Wright P; Nelson SM; Wallace WH
Mol Hum Reprod; 2012 Feb; 18(2):79-87. PubMed ID: 21933846
[TBL] [Abstract][Full Text] [Related]
11. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.
Steiner AZ; Pritchard D; Stanczyk FZ; Kesner JS; Meadows JW; Herring AH; Baird DD
JAMA; 2017 Oct; 318(14):1367-1376. PubMed ID: 29049585
[TBL] [Abstract][Full Text] [Related]
12. Can we predict the age of menopause transition?
Panay N; Fenton A
Climacteric; 2010 Dec; 13(6):507-8. PubMed ID: 21073406
[No Abstract] [Full Text] [Related]
13. [Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence].
Roshchina NV; Tsyrlina EV; Punanov IuA; Safonova SA; Bershteĭn LM; Kostromina EV; Malinin AP; Morozova EV
Vopr Onkol; 2014; 60(3):360-5. PubMed ID: 25033691
[TBL] [Abstract][Full Text] [Related]
14. Possibilities and limits of ovarian reserve testing in ART.
La Marca A; Argento C; Sighinolfi G; Grisendi V; Carbone M; D'Ippolito G; Artenisio AC; Stabile G; Volpe A
Curr Pharm Biotechnol; 2012 Mar; 13(3):398-408. PubMed ID: 21657996
[TBL] [Abstract][Full Text] [Related]
15. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
[TBL] [Abstract][Full Text] [Related]
16. Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years.
Steiner AZ; Herring AH; Kesner JS; Meadows JW; Stanczyk FZ; Hoberman S; Baird DD
Obstet Gynecol; 2011 Apr; 117(4):798-804. PubMed ID: 21422850
[TBL] [Abstract][Full Text] [Related]
17. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
18. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction.
Al-Azemi M; Killick SR; Duffy S; Pye C; Refaat B; Hill N; Ledger W
Hum Reprod; 2011 Feb; 26(2):414-22. PubMed ID: 21147822
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve.
Hudecova M; Holte J; Olovsson M; Sundström Poromaa I
Hum Reprod; 2009 May; 24(5):1176-83. PubMed ID: 19168874
[TBL] [Abstract][Full Text] [Related]
20. Celiac disease does not influence markers of ovarian reserve in adolescent girls.
Comba C; Comba A; Yılmaz H; Erdogan SV; Demir O
Arch Gynecol Obstet; 2020 Nov; 302(5):1263-1269. PubMed ID: 32594297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
